WHITE PAPER
Accelerating Antibody-Drug Conjugate (ADC) Development
Antibody–drug conjugates present unique analytical challenges that require sensitive, reproducible, and high-throughput bio-analytical methods. Automated immunoassay platforms enable CROs to streamline bio-analytical workflows for scalable, more efficient ADC development.
Download the White Paper and
- Understand ADC complexit
Learn how the hybrid structure of ADCs requires multi-analyte assessment beyond traditional antibody workflows - Accelerate your program
Discover how automated immunoassay platforms address critical bottlenecks of common plate-based assays, such as hands-on time, throughput, matrix interference, and sample consumption - See supporting case studies
Review real-world preclinical and clinical examples demonstrating multi-analyte PK and immunogenicity Gyrolab workflows